INKON Life Technology Past Earnings Performance
Past criteria checks 3/6
INKON Life Technology has been growing earnings at an average annual rate of 14.6%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 18% per year. INKON Life Technology's return on equity is 6.1%, and it has net margins of 5.6%.
Key information
14.6%
Earnings growth rate
16.1%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 18.0% |
| Return on equity | 6.1% |
| Net Margin | 5.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How INKON Life Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,595 | 89 | 236 | 47 |
| 30 Jun 24 | 1,570 | 85 | 240 | 50 |
| 31 Mar 24 | 1,526 | 87 | 232 | 53 |
| 31 Dec 23 | 1,471 | 100 | 224 | 52 |
| 30 Sep 23 | 1,396 | -557 | 210 | 57 |
| 30 Jun 23 | 1,305 | -573 | 200 | 46 |
| 31 Mar 23 | 1,250 | -580 | 199 | 36 |
| 01 Jan 23 | 1,156 | -596 | 170 | 28 |
| 30 Sep 22 | 1,106 | -436 | 172 | 21 |
| 30 Jun 22 | 1,129 | -358 | 167 | 25 |
| 31 Mar 22 | 1,116 | -358 | 159 | 28 |
| 01 Jan 22 | 1,090 | -364 | 165 | 29 |
| 30 Sep 21 | 1,388 | 233 | 177 | 26 |
| 30 Jun 21 | 1,281 | 163 | 166 | 21 |
| 31 Mar 21 | 1,170 | 179 | 167 | 18 |
| 31 Dec 20 | 1,029 | 149 | 157 | 17 |
| 30 Sep 20 | 659 | -700 | 130 | 19 |
| 30 Jun 20 | 602 | -700 | 143 | 17 |
| 31 Mar 20 | 567 | -716 | 132 | 14 |
| 31 Dec 19 | 573 | -703 | 129 | 11 |
| 30 Sep 19 | 520 | 21 | 120 | 8 |
| 30 Jun 19 | 508 | 28 | 102 | 8 |
| 31 Mar 19 | 467 | 15 | 100 | 8 |
| 31 Dec 18 | 504 | 50 | 97 | 7 |
| 30 Sep 18 | 471 | 64 | 93 | 4 |
| 30 Jun 18 | 451 | 87 | 81 | 9 |
| 31 Mar 18 | 433 | 107 | 82 | 8 |
| 31 Dec 17 | 329 | 122 | 69 | 7 |
| 30 Sep 17 | 381 | 150 | 69 | 6 |
| 30 Jun 17 | 388 | 122 | 81 | 0 |
| 31 Mar 17 | 390 | 98 | 78 | 0 |
| 31 Dec 16 | 432 | 55 | 91 | 0 |
| 30 Sep 16 | 377 | 32 | 92 | 0 |
| 30 Jun 16 | 329 | 18 | 83 | 0 |
| 31 Mar 16 | 290 | 17 | 73 | 0 |
| 31 Dec 15 | 280 | 11 | 67 | 0 |
| 30 Sep 15 | 289 | -253 | 79 | 0 |
| 30 Jun 15 | 297 | -272 | 84 | 0 |
| 31 Mar 15 | 300 | -294 | 87 | 0 |
| 31 Dec 14 | 308 | -293 | 88 | 0 |
| 30 Sep 14 | 297 | -135 | 83 | 0 |
| 30 Jun 14 | 287 | -132 | 85 | 0 |
| 31 Mar 14 | 274 | -147 | 88 | 0 |
| 31 Dec 13 | 255 | -163 | 91 | 0 |
Quality Earnings: 300143 has high quality earnings.
Growing Profit Margin: 300143 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300143 has become profitable over the past 5 years, growing earnings by 14.6% per year.
Accelerating Growth: 300143 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 300143 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).
Return on Equity
High ROE: 300143's Return on Equity (6.1%) is considered low.